57704-54-8Relevant articles and documents
MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS
-
Paragraph 0486; 0539, (2021/10/15)
The present invention relates to macrocyclic diamine derivatives of formula II, including pharmaceutically acceptable salts and solvates thereof. Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the macrocyclic diamine derivatives with an adenosine receptor antagonist, for the treatment of cancers.
4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives
-
Page/Page column 29, (2010/11/26)
The present invention relates to compounds of the formula medicaments containing them and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as Raf kinase inhibitors and therefore may be useful for the treatment of diseases mediated by said kinases, especially as anticancer agents.
Chiral carboxylic acid ligands derived from camphoric acid
Moloney, Mark G.,Paul, Diana R.,Thompson, Russell M.,Wright, Emma
, p. 2551 - 2562 (2007/10/03)
Versatile and convenient preparations of chiral carboxylic acid ligands, derived from camphoric acid, are described, either by esterification of camphoric dichloride or by a regioselective opening of the corresponding anhydride by a variety of alcohols or diols.